Adverse events1,050

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,050

Type	Event	Organ system	Group	Affected	At risk	Events
other	Hearing impaired	Ear and labyrinth disorders	Regorafenib (Double Blind Only)	1	41	1
other	Hearing impaired	Ear and labyrinth disorders	Placebo (Double Blind Only)	0	8	0
other	Hearing impaired	Ear and labyrinth disorders	Placebo, Open Label Only (Switch to Regorafenib)	1	58	1
other	Hearing impaired	Ear and labyrinth disorders	Treated With Regorafenib at Any Time	7	190	7
other	Hearing impaired	Ear and labyrinth disorders	Treated With Regorafenib for > 1 Year	5	75	5
other	Ear and labyrinth disorders - Other	Ear and labyrinth disorders	Regorafenib (Double Blind Only)	0	41	0
other	Ear and labyrinth disorders - Other	Ear and labyrinth disorders	Placebo (Double Blind Only)	0	8	0
other	Ear and labyrinth disorders - Other	Ear and labyrinth disorders	Placebo, Open Label Only (Switch to Regorafenib)	4	58	4
other	Ear and labyrinth disorders - Other	Ear and labyrinth disorders	Treated With Regorafenib at Any Time	7	190	7
other	Ear and labyrinth disorders - Other	Ear and labyrinth disorders	Treated With Regorafenib for > 1 Year	4	75	4
other	Anemia	Blood and lymphatic system disorders	Regorafenib (Double Blind Only)	4	41	7
other	Anemia	Blood and lymphatic system disorders	Placebo (Double Blind Only)	0	8	0
other	Anemia	Blood and lymphatic system disorders	Placebo, Open Label Only (Switch to Regorafenib)	11	58	25
other	Anemia	Blood and lymphatic system disorders	Treated With Regorafenib at Any Time	35	190	77
other	Anemia	Blood and lymphatic system disorders	Treated With Regorafenib for > 1 Year	17	75	35
other	Blood and lymphatic system disorders - Other	Blood and lymphatic system disorders	Regorafenib (Double Blind Only)	0	41	0
other	Blood and lymphatic system disorders - Other	Blood and lymphatic system disorders	Placebo (Double Blind Only)	0	8	0
other	Blood and lymphatic system disorders - Other	Blood and lymphatic system disorders	Placebo, Open Label Only (Switch to Regorafenib)	2	58	9
other	Blood and lymphatic system disorders - Other	Blood and lymphatic system disorders	Treated With Regorafenib at Any Time	6	190	17
other	Blood and lymphatic system disorders - Other	Blood and lymphatic system disorders	Treated With Regorafenib for > 1 Year	4	75	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01271712/events

API reference For AI assistants

Adverse events1,050

Sources 3

Read this list from software.